Treating MS is expensive, but cost falls over timeMarch 05, 2003The cost of drug treatment multiple sclerosis is high, but decreases with prolonged treatment up to 20 years, concludes a study in this week's BMJ. Researchers evaluated the cost effectiveness of four drugs currently licensed for the treatment of multiple sclerosis in the United Kingdom (three interferon betas and glatiramer acetate). They assessed the effect of each drug against conventional management over 20 years using the best available evidence. They calculated that the cost of each year of life saved or prolonged by using any of the four treatments ranged from £42,000 to £98,000. Price had a considerable effect on the cost effectiveness for each drug. The authors stress, however, that uncertainty surrounding these estimates is substantial, largely due to the unpredictability of the disease and the difficulty in capturing all aspects of its impact on patients. Further research to establish the true impact of these treatments would be of considerable value, they conclude. In the face of such uncertainties, the Department of Health has introduced a risk-sharing scheme for providing these treatments in the NHS, writes Professor David Miller in an accompanying commentary. Although the scheme will need substantial investment, it is a constructive approach in addressing a difficult problem, and it is hard to see a realistic alternative. Further research is needed to identify those who will benefit most from disease modifying treatments. Meanwhile, work must go on to develop more effective treatments, he concludes. British Medical Journal (BMJ) |
|||||||||||||||||||||
| Related Multiple Sclerosis Current Events and Multiple Sclerosis News Articles Multiple health concerns surface as winter, vitamin D deficiences arrive A string of recent discoveries about the multiple health benefits of vitamin D has renewed interest in this multi-purpose nutrient, increased awareness of the huge numbers of people who are deficient in it, spurred research and even led to an appreciation of it as "nature's antibiotic." Factors from common human bacteria may trigger multiple sclerosis Current research suggests that a common oral bacterium may exacerbate autoimmune disease. The related report by Nichols et al, "Unique Lipids from a Common Human Bacterium Represent a New Class of TLR2 Ligands Capable of Enhancing Autoimmunity," appears in the December 2009 issue of The American Journal of Pathology. Drug studied as possible treatment for spinal injuries Researchers have shown how an experimental drug might restore the function of nerves damaged in spinal cord injuries by preventing short circuits caused when tiny "potassium channels" in the fibers are exposed. CSHL team solves structure of NMDA receptor unit that could be drug target for neurological diseases A team of scientists at Cold Spring Harbor Laboratory (CSHL) reports on Thursday their success in solving the molecular structure of a key portion of a cellular receptor implicated in Alzheimer's, Parkinson's, and other serious illnesses. Men leave: Separation and divorce far more common when the wife is the patient A woman is six times more likely to be separated or divorced soon after a diagnosis of cancer or multiple sclerosis than if a man in the relationship is the patient, according to a study that examined the role gender played in so-called "partner abandonment." The study also found that the longer the marriage the more likely it would remain intact. Neurologists Investigate Possible New Underlying Cause of MS Neurologists at the University at Buffalo are beginning a research study that could overturn the prevailing wisdom on the cause of multiple sclerosis (MS). Scientists demonstrate link between genetic defect and brain changes in schizophrenia Researchers at the University of North Carolina at Chapel Hill School of Medicine have found that the 22q11 gene deletion - a mutation that confers the highest known genetic risk for schizophrenia - is associated with changes in the development of the brain that ultimately affect how its circuit elements are assembled. Gentle touch may aid multiple sclerosis patients While gripping, lifting or manipulating an object such as drinking from a cup or placing a book on a shelf is usually easy for most, it can be challenging for those with neurological diseases such as multiple sclerosis or Parkinson's, or for people who had a stroke. For them, the tight gripping can cause fatigue, making everyday tasks difficult. Urate in blood and spinal fluid may predict slower decline in patients with Parkinson's disease Higher concentration of urate (an antioxidant) in the blood and spinal fluid of patients with early Parkinson's disease is associated with slower rates of clinical decline. Oxidized form of a common vitamin may bring relief for ulcerative colitis New research published in the Journal of Leukocyte Biology finds retinoic acid may alleviate ulcerative colitis and similar irritable bowel diseases. More Multiple Sclerosis Current Events and Multiple Sclerosis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||